Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622756 | 1.00 | GRIK1 (0.32) | GRIK1GRIK2 | |
| SCHEMBL14425429 | 0.83 | — | — | |
| SCHEMBL2108417 | 0.78 | GRIK1 (0.31) | GRIK1GRIK2 | |
| SCHEMBL295881 | 0.78 | GRIK1 (0.31) | GRIK1GRIK2 | |
| SCHEMBL11139699 | 0.75 | — | — | |
| SCHEMBL8847968 | 0.74 | TSHR (0.38) | — | |
| SCHEMBL2233286 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL9978452 | 0.66 | DGAT1 (0.38) | — | |
| SCHEMBL10907823 | 0.66 | ALDH1A1 (0.32) | — | |
| SCHEMBL21269713 | 0.66 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1571138-B2 | PROCESSES FOR PRODUCING (4E)-5-CHLORO-2-ISOPROPYL-4-PENTENOIC ESTER AND OPTICALLY ACTIVE ISOMER THEREOF | ASAHI GLASS CO LTD (JP) | 2014-12-17 | — | — | EP | disclosed |
| WO-2012021446-A2 | PROCESS FOR PREPARING ALISKIREN AND ITS INTERMEDIATES | DR. REDDY'S LABORATORIES LTD. (IN) | 2012-02-16 | — | — | WO | disclosed |
| US-7232925-B2 | Process for producing (4E)-5-chloro-2-isopropyl-4-pentenoate and optically active form thereof | ASAHI GLASS COMPANY, LIMITED (JP) | 2007-06-19 | — | — | US | disclosed |
| EP-1571138-B1 | PROCESSES FOR PRODUCING (4E)-5-CHLORO-2-ISOPROPYL-4-PENTENOIC ESTER AND OPTICALLY ACTIVE ISOMER THEREOF | ASAHI GLASS CO LTD (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-20050228193-A1 | Process for producing (4E)-5-chloro-2-isopropyl-4-pentenoate and optically active form thereof | ASAHI GLASS COMPANY LIMITED (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1571138-A1 | PROCESSES FOR PRODUCING (4E)-5-CHLORO-2-ISOPROPYL-4-PENTENOIC ESTER AND OPTICALLY ACTIVE ISOMER THEREOF | ASAHI GLASS COMPANY LTD. (JP) | 2005-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050228193-A1 | Process for producing (4E)-5-chloro-2-isopropyl-4-pentenoate and optically active form thereof | C5, ALOX5, PTGER4 | GRIK1 2747/4885GRIK2 2313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.